Statistics for First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults

Total visits

views
First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults 0

Total visits per month

views
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 0
July 2024 0

File Visits

views
First-in-human trial of the post-exposure tuberculosis vaccine H56IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults.pdf 1